20N Bio Raises $3.3 Million In Series Seed Funding To Advance Computational Design Of New Proteins For Therapeutics
Amount Raised
$3.3 Million
Round Type
Seed
Description
20n Bio (20n), an artificial intelligence (AI)-powered drug discovery company focusing on designing new proteins for therapeutics, has raised a $3.3 million seed round led by BlueRun Ventures China. 20n Bio will use the proceeds from the financing to expand its scientific team, establish a robust discovery platform, and start multiple early studies in oncology and other genetic diseases.
Quick answer
20n Bio raised $3.3 Million in a Seed round, dated December 17, 2021.
- How much did 20n Bio raise?
- 20n Bio raised $3.3 Million in a Seed round on December 17, 2021.
- What does 20n Bio do?
- 20n Bio is a VC-backed start-up dedicated to the computational design of novel proteins for therapeutics.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as 20n Bio that raised within 45 days of this round, from Fundz verified event records.
- Septerna raised $100M (Series A) on January 27, 2022.
- Advanced NanoTherapies raised $9.2M on January 26, 2022.
- Kyverna Therapeutics raised $85M (Series B) on January 26, 2022.
- Enliven Therapeutics raised an undisclosed amount (Funding Round) on January 19, 2022.
- Feldan Therapeutics raised an undisclosed amount (Funding Round) on January 18, 2022.
- PostEra Inc. raised $26M on January 14, 2022.
Who to call at 20n Bio, and when
A new round usually means 20n Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day 20n Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at 20n Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at 20n Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment 20n Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
20n Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.